TrypsiNNex® is a new animal-free trypsin in Excipient GMP quality
TrypsiNNex® will minimize risk of viral contamination and improve process consistency from unmatched high trypsin purity with a highly stable β-content typically well above 70%.
Benefits of TrypsiNNex®:
- Reduce costs by minimizing risk of viral contamination.
- Improve process consistency from unmatched high trypsin purity with a highly stable β-content typically well above 70% giving increased activity and long-lasting performance.
- Easy qualification due to extensive documentation from a preferred pharma grade supplier.
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Novo Nordisk Pharmatech A/S was established in 1949. It is the leading worldwide supplier of recombinant insulin, which is sourced directly from Novo Nordisk, the world’s largest producer. Its recombinant insulin is a key component in serum free growth media for mammalian cells and approved by regulatory bodies worldwide, including FDA and EMA. The company’s products are manufactured to cGMP standards, and have distinguished itself for:
- Global regulatory compliance
- Consistent high quality
- Extensive regulatory documentation
- Continuous availability
- Secure global supply chain
- High levels of service and support
